TRPA1 targeting mAb (Juno)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTRPA1 targeting mAb (Juno)
Drug Alias NameTRPA1 targeting mAb (X-BODY BioSciences)transient receptor potential cation channel A1 targeting mAb (X-BODY BioSciences)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTransient receptor potential cation channel subfamily A member 1 modulators
TargetsTransient receptor potential cation channel subfamily A member 1
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesX-BODY BioSciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesX-BODY BioSciencesJuno Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A